Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Growth Equity Opportunities Fund IV, LLC
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
Company Symbol Insider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2020-06-19
Purchase
2020-06-22
5:26 pm
AVEO PHARMACEUTICALS Inc AVEO Growth Equity Opportunities Fund IV LLC
New Enterprise Associates 15 L.P.
NEA Partners 15 L.P.
NEA 15 GP LLC
10% Owner
1,428,571 $5.25 $7,499,998 3,952,958
(Direct)
View
2019-04-08
Purchase
2019-04-08
5:18 pm
AVEO PHARMACEUTICALS INC AVEO Growth Equity Opportunities Fund IV LLC
NEA 15 GP LLC
NEA Partners 15 L.P.
New Enterprise Associates 15 L.P.
10% Owner
4,347,827 $1.14 $4,956,523 29,591,692
(Direct)
View
2018-12-20
Purchase
2018-12-21
9:15 pm
AVEO PHARMACEUTICALS INC AVEO Growth Equity Opportunities IV LLC
NEA 15 GP LLC
NEA Partners 15 L.P.
New Enterprise Associates 15 L.P.
10% Owner
500,000 $1.5489 $774,440 20,896,038
(Direct)
View
2018-12-11
Purchase
2018-12-12
4:40 pm
AVEO PHARMACEUTICALS INC AVEO Growth Equity Opportunities IV LLC
NEA 15 GP LLC
NEA Partners 15 L.P.
New Enterprise Associates 15 L.P.
10% Owner
61,200 $1.9785 $121,084 20,396,038
(Direct)
View
2018-12-06
Purchase
2018-12-10
5:18 pm
AVEO PHARMACEUTICALS INC AVEO Growth Equity Opportunities IV LLC
NEA 15 GP LLC
NEA Partners 15 L.P.
New Enterprise Associates 15 L.P.
10% Owner
170,400 $1.9856 $338,352 20,334,838
(Direct)
View
2018-11-28
Purchase
2018-11-30
5:10 pm
AVEO PHARMACEUTICALS INC AVEO Growth Equity Opportunities IV LLC
NEA 15 GP LLC
NEA Partners 15 L.P.
New Enterprise Associates 15 L.P.
10% Owner
96,400 $1.9802 $190,891 20,164,438
(Direct)
View
2018-11-20
Purchase
2018-11-21
4:41 pm
AVEO PHARMACEUTICALS INC AVEO Growth Equity Opportunities IV LLC
NEA 15 GP LLC
NEA Partners 15 L.P.
New Enterprise Associates 15 L.P.
10% Owner
170,000 $1.9771 $336,107 20,068,038
(Direct)
View
2018-11-15
Purchase
2018-11-19
7:39 pm
AVEO PHARMACEUTICALS INC AVEO Growth Equity Opportunities IV LLC
NEA 15 GP LLC
NEA Partners 15 L.P.
New Enterprise Associates 15 L.P.
10% Owner
1,200,000 $1.865 $2,237,971 19,898,038
(Direct)
View
2018-08-21
Purchase
2018-08-22
4:42 pm
AVEO PHARMACEUTICALS INC AVEO Growth Equity Opportunities IV LLC
NEA 15 GP LLC
NEA Partners 15 L.P.
New Enterprise Associates 15 L.P.
10% Owner
663,716 $2.26 $1,499,998 18,698,038
(Direct)
View
2018-07-18
Purchase
2018-07-20
4:40 pm
AVEO PHARMACEUTICALS INC AVEO Growth Equity Opportunities IV LLC
NEA 15 GP LLC
NEA Partners 15 L.P.
New Enterprise Associates 15 L.P.
10% Owner
250,600 $1.9623 $491,745 18,034,322
(Direct)
View
2018-06-27
Purchase
2018-06-28
7:09 pm
AVEO PHARMACEUTICALS INC AVEO Growth Equity Opportunities IV LLC
NEA 15 GP LLC
NEA Partners 15 L.P.
New Enterprise Associates 15 L.P.
10% Owner
192,425 $2.0999 $404,077 17,783,722
(Direct)
View
2018-05-30
Purchase
2018-05-30
5:09 pm
AVEO PHARMACEUTICALS INC AVEO Growth Equity Opportunities IV LLC
NEA 15 GP LLC
NEA Partners 15 L.P.
New Enterprise Associates 15 L.P.
10% Owner
275 $2.15 $591 17,591,297
(Direct)
View
2018-05-17
Purchase
2018-05-21
5:23 pm
AVEO PHARMACEUTICALS INC AVEO Growth Equity Opportunities IV LLC
NEA 15 GP LLC
NEA Partners 15 L.P.
New Enterprise Associates 15 L.P.
10% Owner
236,479 $2.1288 $503,423 17,591,022
(Direct)
View
2018-05-08
Purchase
2018-05-10
5:00 pm
AVEO PHARMACEUTICALS INC AVEO Growth Equity Opportunities IV LLC
NEA 15 GP LLC
NEA Partners 15 L.P.
New Enterprise Associates 15 L.P.
10% Owner
70,873 $2.1341 $151,250 17,354,543
(Direct)
View
2018-04-06
Purchase
2018-04-10
5:28 pm
AVEO PHARMACEUTICALS INC AVEO Growth Equity Opportunities IV LLC
NEA 15 GP LLC
NEA Partners 15 L.P.
New Enterprise Associates 15 L.P.
10% Owner
920,976 $2.2965 $2,115,036 17,283,670
(Direct)
View
2018-02-26
Sale
2018-02-27
4:34 pm
ARCA biopharma Inc. ABIO Growth Equity Opportunities IV LLC
New Enterprise Associates 15 L.P.
NEA Partners 15 L.P.
NEA 15 GP LLC
10% Owner
1,460,209 $0.5008 $731,273 0
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2022-10-19
Other
2022-10-21
4:36 pm
N/A
N/A
AVEO PHARMACEUTICALS Inc AVEO Growth Equity Opportunities Fund IV LLC
10% Owner
3,952,957 $0 3,952,957
(Direct)
View
2018-03-09
Equity Swap
2018-03-13
6:06 pm
N/A
N/A
Cascadian Therapeutics Inc. CASC Growth Equity Opportunities IV LLC
New Enterprise Associates 15 L.P.
NEA Partners 15 L.P.
NEA 15 GP LLC
10% Owner
10,882,574 $0 0
(Direct)
View
2018-02-20
Conversion
2018-02-22
4:41 pm
N/A
N/A
Cascadian Therapeutics Inc. CASC Growth Equity Opportunities IV LLC
New Enterprise Associates 15 L.P.
NEA Partners 15 L.P.
NEA 15 GP LLC
10% Owner
1,818,000 $0 10,882,574
(Direct)
View
2018-02-20
Conversion
2018-02-22
4:41 pm
N/A
N/A
Cascadian Therapeutics Inc. CASC Growth Equity Opportunities IV LLC
New Enterprise Associates 15 L.P.
NEA Partners 15 L.P.
NEA 15 GP LLC
10% Owner
1,818,000 $3.3 10,882,574
(Direct)
View